Mackay Shields LLC’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,282
Closed -$2.37M 367
2022
Q1
$2.37M Sell
17,282
-1,204
-7% -$168K 0.02% 526
2021
Q4
$3.2M Sell
18,486
-343
-2% -$52.2K 0.03% 469
2021
Q3
$2.74M Sell
18,829
-1,869
-9% -$273K 0.03% 475
2021
Q2
$2.73M Sell
20,698
-1,582
-7% -$207K 0.03% 482
2021
Q1
$2.86M Sell
22,280
-8,649
-28% -$1.07M 0.02% 619
2020
Q4
$3.69M Buy
30,929
+8,139
+36% +$992K 0.03% 582
2020
Q3
$2.61M Buy
22,790
+1,310
+6% +$155K 0.02% 677
2020
Q2
$2.45M Buy
21,480
+745
+4% +$79K 0.02% 669
2020
Q1
$1.67M Sell
20,735
-101
-0.5% -$10.5K 0.02% 747
2019
Q4
$2.23M Sell
20,836
-1,474
-7% -$154K 0.02% 832
2019
Q3
$2.39M Buy
22,310
+1,947
+10% +$200K 0.01% 831
2019
Q2
$2.07M Buy
20,363
+400
+2% +$38.4K 0.01% 885
2019
Q1
$1.79M Sell
19,963
-7,978
-29% -$691K 0.01% 741
2018
Q4
$2.33M Buy
27,941
+6,144
+28% +$576K 0.02% 636
2018
Q3
$2.35M Sell
21,797
-282
-1% -$30.9K 0.02% 664
2018
Q2
$2.43M Sell
22,079
-860
-4% -$89.6K 0.02% 712
2018
Q1
$2.3M Buy
+22,939
New +$2.35M 0.01% 747

Other funds holding DGX

Mackay Shields LLC's DGX Position: Q2 2022 in Review

Mackay Shields LLC sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 17,282 shares — an estimated $2.37M sold.

Mackay Shields LLC first reported a position in DGX in Q1 2018 and held it in 17 quarters. The position peaked at $3.69M in Q4 2020. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Mackay Shields LLC reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 17,282 Quest Diagnostics shares in Q2 2022, an estimated $2.37M.
  • Mackay Shields LLC first reported a position in Quest Diagnostics in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Quest Diagnostics position peaked at $3.69M in Q4 2020.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.